Covid-19 Daily Update:South Africa breaches 1,200 mark in 24 hours.
By Lehlohonolo Lehana.
The National Institute for Communicable Diseases (NICD), reports 1,275 new COVID-19 cases that have been identified in South Africa, which brings the total number of laboratory-confirmed cases to 2,950,035. This increase represents a 3.6% positivity rate.
The majority of new cases today are from Gauteng (80%), followed Western Cape for 5%. KwaZulu-Natal and North West each accounted for 3% respectively; Eastern Cape, Limpopo, and Mpumalanga each accounted for 2% respectively; and Free State and Northern Cape each accounted for 1% respectively of today’s new cases.
NICD said a further 22 COVID-19 related deaths have been reported, bringing total fatalities to 89,657 to date.
Globally, the World Health Organisation (WHO) said the numbers of weekly COVID-19 cases and deaths have increased for more than a month.
According to the weekly epidemiological update, nearly 3.6 million confirmed new cases and over 51 000 deaths were reported between 15 and 21 November 2021.
This reflects a 6% increase in cases and deaths as compared to the previous week.
The European region logged an 11% increase in new weekly cases, while the other regions reported a decrease or similar incident to the previous week.
While the Western Pacific and Americas recorded "relatively" stable case incidence, they both reported a large spike in new weekly deaths, 29% and 19% respectively.
In contrast, the African and the South-East Asia regions reported a 30% and 19% decrease in new weekly deaths.
The cumulative number of confirmed cases reported globally now stands at over 256 million and more than 5.1 million deaths.
The highest numbers of new cases were reported from the United States (558 538 new cases, similar to the previous week), Germany (333 473 new cases, 31% increase), the United Kingdom (281 063 new cases, 11% increase), Russia (260 484 new cases, similar to the previous week) and Turkey (163 835 new cases, 9% decrease).
In addition, the agency said the current global epidemiology of SARS-CoV-2 is characterised by a predominance of the Delta variant.